updat model tax reform dmg
sale capit deploy reiter buy
net dbt
rais ests/po tax reform dmg sale share repo
highlight stabl commerci rate outlook reiter kidney
oper incom oi guidanc addit quantifi impact tax reform
sustain benefit gave color sale davita medic group
dmg use proce note largest percentag proce far
go share repurchas think commentari well receiv
lower ebitda estim dmg sale rais ep estim tax
reform share repurchas po move ebitda
compani focus stabl recur high cf dialysi busi
reiter buy rate stabil commerci outlook share repo upsid
remain top hc facil pick
note four five largest payer lock signific lt contract
fifth close contribut stabl commerci rate outlook continu expect
dialysi oi impli core growth ex hurrican comp
account headwind continu view conserv
rang would expect lt despit commerci price stabil potenti
epo save emphas stabl dialysi cf expect chang
near futur final highlight ca ballot initi min staf potenti
headwind recogn risk look color
tax reform benefit line expect
expect tax rate fall heel tax
reform expect st cf benefit acceler depreci near-term impact
interest deduct line expect meanwhil expect one-tim net
benefit defer tax balanc excess final expect
sustain tax reform benefit vs estimate
largest dmg sale proce use share repo
largest percentag proce dmg sale go repo remaind
use debt repay invest servic commentari
well receiv drive ep growth maintain rel stabl leverag ratio
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
davita inc lead dialysi provid
unit state compani oper
outpati clinic us serv
patient also oper
countri outsid us
commerci mix price stabil bode
well particularli given conserv
initi guidanc addit continu view
sale davita medic group dmg
posit use proce share
repurchas debt repay invest
health care servic outsid dialysi
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
po base ebitda estim high end
stand-alon histor rang ebitda commerci outlook
stabil dmg sale allow focu core dialysi busi
upsid risk po commerci mix better expect
reimburs better expect make chang third
downsid risk po commerci price pressur could continu
potenti commerci mix pressur manag care vast major dialysi
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
